Is BrightSpring Health Services, Inc. overvalued or undervalued?

As of 5 August 2025, the valuation grade for BrightSpring Health Services, Inc. has moved from expensive to attractive, indicating a shift in perception towards the stock's value. Based on the current metrics, the company appears undervalued, with a P/E ratio of 37, an EV to EBITDA of 12.65, and a PEG ratio of 0.12. In comparison, a peer such as BrightSpring Health Services, Inc. has a P/E of 37.784 and an EV to EBITDA of 13.2063, suggesting that BrightSpring is positioned favorably within its industry.
The company's recent performance has been notable, with a year-to-date return of 60.01% compared to the S&P 500's 12.22%, and a one-year return of 83.25% against the S&P 500's 17.14%. This strong performance reinforces the attractiveness of the stock, supporting the conclusion that it is currently undervalued.